Recombinant Monkeypox virus/MPXV A14L Protein

The recombinant Monkeypox virus A14L protein (MPXV A14L) is produced in an Escherichia coli expression system and purified for use in research applications. Viral structural proteins such as A14L are important components of orthopoxvirus biology and are commonly used in studies investigating viral replication, host–virus interactions, and antiviral strategies.

This recombinant MPXV protein enables researchers to study Monkeypox virus protein structure, immune responses, and viral pathogenesis in controlled experimental systems.

Biological Background

Monkeypox virus (MPXV) is a member of the Orthopoxvirus genus, which also includes variola virus and vaccinia virus. Viral structural proteins play important roles in virus assembly and infection processes.

The A14L protein is associated with viral membrane formation and structural organization during the viral replication cycle. Recombinant viral proteins are widely used for:

• virology research
• vaccine and antigen development
• antibody generation
• viral protein characterization
• host–virus interaction studies

Applications

This recombinant MPXV A14L protein can be used in multiple experimental applications, including:

• ELISA development and antigen detection assays
• antibody generation and validation
• viral protein interaction studies
• immunological assays
• structural and biochemical studies

Recombinant Monkeypox Protein Price

ProteoGenix offers competitive pricing for recombinant viral proteins, allowing laboratories to access high-quality reagents while controlling research costs.

Our recombinant proteins are produced under controlled conditions to ensure reproducibility, purity, and consistent experimental performance.

Research Use Only (RUO): This product is intended for laboratory research purposes only and is not intended for diagnostic, therapeutic, or clinical use

Related Services

• Protein Production
• Custom Antibody Production
• High-throughput antibody production services